From: Impact of pharmacy channel on adherence to oral oncolytics
Characteristica | Specialty | Traditional Retail | P-value | ||
---|---|---|---|---|---|
Number of Patients | 11,972 | 30,394 | |||
Abandonment of Index Prescription | <0.001 | ||||
Approved Without Challenges, N (%) | 11,731 | 98.0% | 28,788 | 94.7% | |
Initial Challenge but Overcome, N (%) | 118 | 1.0% | 875 | 2.9% | |
Initial Challenge Unknown if Overcome, N (%)b | 3 | 0.0% | 43 | 0.1% | |
Abandoned, N (%)c | 97 | 0.8% | 604 | 2.0% | |
Unknown, N (%)d | 23 | 0.2% | 84 | 0.3% | |
Adherence - Proportion of Days Covered between the First and Last Fille | |||||
Mean (SD) | 0.86 (0.2) | 0.79 (0.2) | <0.001 | ||
Number with >1 fill | 9194 | 22,219 | |||
Adherent, N (%) | 6586 | 71.6% | 12,542 | 56.4% | <0.001 |
Adherence - Proportion Days Covered between First and Last Fill, N (%) | <0.001 | ||||
0–0.20 | 12 | 0.1% | 246 | 1.1% | |
0.21–0.40 | 241 | 2.6% | 1273 | 5.7% | |
0.41–0.60 | 984 | 10.7% | 3815 | 17.2% | |
0.61–0.70 | 733 | 8.0% | 2571 | 11.6% | |
0.70–0.79 | 638 | 6.9% | 1772 | 8.0% | |
0.80–0.90 | 965 | 10.5% | 2182 | 9.8% | |
0.90–1.00 | 5621 | 61.1% | 10,360 | 46.6% | |
Persistencef,g - Time until Discontinuation of Index Oncolytic (days) | |||||
Number Filling Prescription for Index Oncolytic | 11,849 | 29,663 | |||
Mean (SD) | 186.2 (235.2) | 161.8 (218.5) | <0.001 | ||
Median | 94 | 83 | |||
Minimum–Maximum | 0–1622 | 0–1613 |